REVELATION BIOSCIENCES, INC.
40 SEC EDGAR filings indexed (CIK 0001810560) across 10 form types.
Filing profile
REVELATION BIOSCIENCES, INC. (REVB) has 40 SEC filings indexed on SecFilingDex, across 10 form types filed over roughly 2 years, from December 20, 2024 to August 19, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 30 of these filings were disclosed in the twelve months to August 19, 2026. 1 of the 40 is an amendment (a corrected or updated version of an earlier filing).
Disclosure mix
- 88-KMaterial event · event-driven
- 8Form 4Insider transaction · within 2 business days of transaction
- 510-QQuarterly report · quarterly
- 5DEF 14AProxy statement · annual (pre-meeting)
- 5PRE 14ASEC filing
- 4424B3Updated prospectus · event-driven
- 210-KAnnual report · annual
- 1S-1/AIPO registration · event-driven (pre-ipo)
- 1S-1IPO registration · event-driven (pre-ipo)
- 1DEFA14ASEC filing
Profile derived from 40 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
- 8-KMaterial event · period of report Aug 17, 2026Filed · 0001193125-26-357120
- Form 4Insider transaction · period of report Aug 17, 2026Filed · 0001193125-26-355658
- Form 4Insider transaction · period of report Aug 17, 2026Filed · 0001193125-26-355659
- Form 4Insider transaction · period of report Aug 17, 2026Filed · 0001193125-26-355661
- Form 4Insider transaction · period of report Aug 17, 2026Filed · 0001193125-26-355662
- Form 4Insider transaction · period of report Aug 17, 2026Filed · 0001193125-26-355663
- 10-QQuarterly report · period of report Jun 30, 2026Filed · 0001193125-26-337967
- 8-KMaterial event · period of report Aug 6, 2026Filed · 0001193125-26-338097
- 8-KMaterial event · period of report Jul 10, 2026Filed · 0001193125-26-302008
- 8-KMaterial event · period of report Jun 24, 2026Filed · 0001193125-26-281200
- 8-KMaterial event · period of report Jun 1, 2026Filed · 0001193125-26-251784
- DEF 14AProxy statement · period of report Jun 24, 2026Filed · 0001193125-26-215804
- 10-QQuarterly report · period of report Mar 31, 2026Filed · 0001193125-26-211871
- 8-KMaterial event · period of report May 7, 2026Filed · 0001193125-26-212064
- Form 4Insider transaction · period of report Apr 30, 2026Filed · 0001193125-26-201764
- Form 4Insider transaction · period of report Apr 30, 2026Filed · 0001193125-26-201769
- PRE 14ASEC filingFiled · 0001193125-26-196729
- 8-KMaterial event · period of report Mar 18, 2026Filed · 0001193125-26-116012
- 10-KAnnual report · period of report Dec 31, 2025Filed · 0001193125-26-076552
- 8-KMaterial event · period of report Nov 6, 2025Filed · 0001193125-26-076833
- DEF 14AProxy statement · period of report Feb 14, 2026Filed · 0001193125-26-053984
- 424B3Updated prospectusFiled · 0001193125-26-046891
- PRE 14ASEC filing · period of report Feb 6, 2026Filed · 0001193125-26-041273
- Form 4Insider transaction · period of report Feb 3, 2026Filed · 0001193125-26-039700
- DEF 14AProxy statement · period of report Dec 3, 2025Filed · 0001193125-25-273712
- 10-QQuarterly report · period of report Sep 30, 2025Filed · 0001193125-25-269450
- PRE 14ASEC filing · period of report Oct 30, 2025Filed · 0001193125-25-258785
- 424B3Updated prospectusFiled · 0001193125-25-225254
- DEF 14AProxy statement · period of report Sep 22, 2025Filed · 0001193125-25-211333
- PRE 14ASEC filing · period of report Sep 11, 2025Filed · 0000950170-25-114524
- 10-QQuarterly report · period of report Jun 30, 2025Filed · 0000950170-25-105284
- DEF 14AProxy statement · period of report May 29, 2025Filed · 0000950170-25-083815
- 424B3Updated prospectusFiled · 0000950170-25-078627
- PRE 14ASEC filing · period of report May 28, 2025Filed · 0000950170-25-078948
- S-1/AIPO registrationFiled · 0001213900-25-047104
- S-1IPO registrationFiled · 0001213900-25-045828
- 10-QQuarterly report · period of report Mar 31, 2025Filed · 0000950170-25-066897
- 10-KAnnual report · period of report Dec 31, 2024Filed · 0000950170-25-034584
- DEFA14ASEC filingFiled · 0000950170-25-004619
- 424B3Updated prospectusFiled · 0000950170-24-139141
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.